Characterization and corroboration of safety signals identified from the US Food and Drug Administration Adverse Event Reporting System, 2008-19: cross sectional study

OBJECTIVE: To characterize potential drug safety signals identified from the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS), from 2008 to 2019, to determine how often these signals resulted in regulatory action by the FDA and whether these actions were corroborated by p...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhodapkar, Meera M, Shi, Xiaoting, Ramachandran, Reshma, Chen, Evan M, Wallach, Joshua D, Ross, Joseph S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533298/
https://www.ncbi.nlm.nih.gov/pubmed/36198428
http://dx.doi.org/10.1136/bmj-2022-071752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533298/
https://www.ncbi.nlm.nih.gov/pubmed/36198428
http://dx.doi.org/10.1136/bmj-2022-071752

Ejemplares similares